Previous Article | Next Article 
Journal of Virology, December 1999, p. 9796-9802, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Herpes Simplex Virus Type 2 Glycoprotein G-Negative
Clinical Isolates Are Generated by Single Frameshift
Mutations
Jan-Åke
Liljeqvist,*
Bo
Svennerholm, and
Tomas
Bergström
Department of Virology, University of
Göteborg, S-413 46 Göteborg, Sweden
Received 20 May 1999/Accepted 20 August 1999
Herpes simplex virus (HSV) codes for several envelope
glycoproteins, including glycoprotein G-2 (gG-2) of HSV type 2 (HSV-2), which are dispensable for replication in cell culture. However, clinical isolates which are deficient in such proteins occur rarely. We
describe here five clinical HSV-2 isolates which were found to be
unreactive to a panel of anti-gG-2 monoclonal antibodies and therefore
considered phenotypically gG-2 negative. These isolates were further
examined for expression of the secreted amino-terminal and
cell-associated carboxy-terminal portions of gG-2 by immunoblotting and
radioimmunoprecipitation. The gG-2 gene was completely inactivated in
four isolates, with no expression of the two protein products. For one
isolate a normally produced secreted portion and a truncated carboxy-terminal portion of gG-2 were detected in virus-infected cell
medium. Sequencing of the complete gG-2 gene identified a single
insertion or deletion of guanine or cytosine nucleotides in all five
strains, resulting in a premature termination codon. The frameshift
mutations were localized within runs of five or more guanine or
cytosine nucleotides and were dispersed throughout the gene. For the
isolate for which a partially inactivated gG-2 gene was detected, the
frameshift mutation was localized upstream of but adjacent to the
nucleotides coding for the transmembranous region. Thus, this study
demonstrates the existence of clinical HSV-2 isolates which do not
express an envelope glycoprotein and identifies the underlying
molecular mechanism to be a single frameshift mutation.
*
Corresponding author. Mailing address: Department of
Virology, University of Göteborg, Guldhedsgatan 10 B, S-413 46 Göteborg, Sweden. Phone: 46-31-3424657. Fax: 46-31-3424960. E-mail: jan-ake.liljeqvist{at}microbio.gu.se.
Journal of Virology, December 1999, p. 9796-9802, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gorander, S., Lagergard, T., Romanik, M., Viscidi, R. P., Martirosian, G., Liljeqvist, J.-A.
(2008). Seroprevalences of Herpes Simplex Virus Type 2, Five Oncogenic Human Papillomaviruses, and Chlamydia trachomatis in Katowice, Poland. CVI
15: 675-680
[Abstract]
[Full Text]
-
Adamiak, B., Ekblad, M., Bergstrom, T., Ferro, V., Trybala, E.
(2007). Herpes Simplex Virus Type 2 Glycoprotein G Is Targeted by the Sulfated Oligo- and Polysaccharide Inhibitors of Virus Attachment to Cells. J. Virol.
81: 13424-13434
[Abstract]
[Full Text]
-
Norberg, P., Kasubi, M. J., Haarr, L., Bergstrom, T., Liljeqvist, J.-A.
(2007). Divergence and Recombination of Clinical Herpes Simplex Virus Type 2 Isolates. J. Virol.
81: 13158-13167
[Abstract]
[Full Text]
-
Perelygina, L., Patrusheva, I., Hombaiah, S., Zurkuhlen, H., Wildes, M. J., Patrushev, N., Hilliard, J.
(2005). Production of Herpes B Virus Recombinant Glycoproteins and Evaluation of Their Diagnostic Potential. J. Clin. Microbiol.
43: 620-628
[Abstract]
[Full Text]
-
Reddy, S. M., Balakrishnan, P., Uma, S., Thyagarajan, S. P., Solomon, S.
(2005). Performance of Two Commercial Enzyme-Linked Immunosorbent Assay Kits Using Recombinant Glycoprotein G2 Antigen for Detection of Herpes Simplex Virus Type 2 Specific Antibodies. CVI
12: 359-360
[Abstract]
[Full Text]
-
Eriksson, K., Bellner, L., Gorander, S., Lowhagen, G.-B., Tunback, P., Rydberg, K., Liljeqvist, J.-A.
(2004). CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals. J. Gen. Virol.
85: 2139-2147
[Abstract]
[Full Text]
-
Wales, S. Q., Smith, C. C., Wachsman, M., Calton, G., Aurelian, L.
(2004). Performance and Use of a Ribonucleotide Reductase Herpes Simplex Virus Type-Specific Serological Assay. CVI
11: 42-49
[Abstract]
[Full Text]
-
Gorander, S., Svennerholm, B., Liljeqvist, J.-A.
(2003). Secreted Portion of Glycoprotein G of Herpes Simplex Virus Type 2 Is a Novel Antigen for Type-Discriminating Serology. J. Clin. Microbiol.
41: 3681-3686
[Abstract]
[Full Text]
-
Xue, S.-A., Jones, M. D., Lu, Q.-L., Middeldorp, J. M., Griffin, B. E.
(2003). Genetic Diversity: Frameshift Mechanisms Alter Coding of a Gene (Epstein-Barr Virus LF3 Gene) That Contains Multiple 102-Base-Pair Direct Sequence Repeats. Mol. Cell. Biol.
23: 2192-2201
[Abstract]
[Full Text]
-
Ikoma, M., Liljeqvist, J.-A., Groen, J., Glazenburg, K. L., The, T. H., Welling-Wester, S.
(2002). Use of a Fragment of Glycoprotein G-2 Produced in the Baculovirus Expression System for Detecting Herpes Simplex Virus Type 2-Specific Antibodies. J. Clin. Microbiol.
40: 2526-2532
[Abstract]
[Full Text]
-
Hirano, M., Nakamura, S., Mitsunaga, F., Okada, M., Shirahama, S., Eberle, R.
(2002). One-Step PCR To Distinguish B Virus from Related Primate Alphaherpesviruses. CVI
9: 716-719
[Abstract]
[Full Text]
-
Eing, B. R., Lippelt, L., Lorentzen, E. U., Hafezi, W., Schlumberger, W., Steinhagen, K., Kuhn, J. E.
(2002). Evaluation of Confirmatory Strategies for Detection of Type-Specific Antibodies against Herpes Simplex Virus Type 2. J. Clin. Microbiol.
40: 407-413
[Abstract]
[Full Text]
-
Liljeqvist, J.-A., Trybala, E., Hoebeke, J., Svennerholm, B., Bergstrom, T.
(2002). Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J. Gen. Virol.
83: 157-165
[Abstract]
[Full Text]
-
Liljeqvist, J.-A., Svennerholm, B., Bergström, T.
(2000). Conservation of Type-Specific B-Cell Epitopes of Glycoprotein G in Clinical Herpes Simplex Virus Type 2 Isolates. J. Clin. Microbiol.
38: 4517-4522
[Abstract]
[Full Text]